Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression

Liang Shi(National Instruments (Ireland)), Chawnshang Chang(China Medical University), Gonghui Li(Sir Run Run Shaw Hospital), Hui Lin(Ningbo University), Ren-An Jin(Sir Run Run Shaw Hospital), Shuyuan Yeh(University of Rochester Medical Center), Wen‐Lung Ma(Asia University), Junjie Xu(Kunming University of Science and Technology), Yin Sun(University of Rochester Medicine), Xiujun Cai(National Instruments (Ireland))
Molecular Cancer Therapeutics
March 3, 2016
Cited by 58


Related Papers